HMGB1 and Axenfeld-Rieger syndrome: In our current study, the data demonstrated that nasal drops of EP (20 ul, twice a day) significantly decreased scores of HMGB1 immunostaining and mRNA expression, and lowered the serum content of HMGB1, TNF-α, and IL-6 in ARS rats.